160 related articles for article (PubMed ID: 10367537)
1. [The role of gemcitabine in the treatment of bladder tumors].
Cortesi E; Gareri R
Clin Ter; 1999; 150(1):5-6. PubMed ID: 10367537
[No Abstract] [Full Text] [Related]
2. Gemcitabine in bladder cancer.
El Karak F; Flechon A
Expert Opin Pharmacother; 2007 Dec; 8(18):3251-6. PubMed ID: 18035967
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer.
Nativ O; Dalal E; Laufer M; Sabo E; Aronson M
Urology; 2004 Oct; 64(4):845-8. PubMed ID: 15491745
[TBL] [Abstract][Full Text] [Related]
4. Treatment of metastatic urothelial cancer in the post-MVAC era.
Cohen EE; Stadler WM
World J Urol; 2001 Apr; 19(2):126-32. PubMed ID: 11374315
[TBL] [Abstract][Full Text] [Related]
5. PHARMAC's response on gemcitabine and transparency.
Crausaz S; Metcalfe S
N Z Med J; 2005 Nov; 118(1225):U1741. PubMed ID: 16286949
[No Abstract] [Full Text] [Related]
6. [The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.1].
Conti G
Arch Ital Urol Androl; 2006 Dec; 78(4 Suppl 1):9-10. PubMed ID: 17491549
[No Abstract] [Full Text] [Related]
7. Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.
Gontero P; Marini L; Frea B
BJU Int; 2005 Nov; 96(7):970-6. PubMed ID: 16225511
[No Abstract] [Full Text] [Related]
8. [Toxicity of intravesical gemcitabine in superficial bladder cancer treatment].
Beardo Villar P; Gamaza Martínez R; Gavira Moreno R
Farm Hosp; 2014 May; 38(3):249-51. PubMed ID: 24951911
[TBL] [Abstract][Full Text] [Related]
9. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
Mermershtain W; Cohen AD; Lazarev I; Grunwald M; Ariad S
J Chemother; 2003 Oct; 15(5):510-1. PubMed ID: 14598945
[TBL] [Abstract][Full Text] [Related]
10. Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.
Gebbia V; Testa A; Borsellino N; Mauceri G; Varvara F; Tirrito ML; Sambataro D; Fallica G
Clin Ter; 1999; 150(1):11-5. PubMed ID: 10367539
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine in the treatment of bladder cancer.
Ryan CW; Vogelzang NJ
Expert Opin Pharmacother; 2000 Mar; 1(3):547-53. PubMed ID: 11249537
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium.
Bellmunt J; Albiol S; de Olano AR; Pujadas J; Maroto P;
Ann Oncol; 2006 May; 17 Suppl 5():v113-7. PubMed ID: 16807437
[TBL] [Abstract][Full Text] [Related]
13. Editorial Comment to Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer.
Gauthier H; Culine S
Int J Urol; 2015 May; 22(5):495. PubMed ID: 25781643
[No Abstract] [Full Text] [Related]
14. Efficacy of bladder perfusion of alternating hydroxycamptothecin and gemcitabine combined with low-dose tuberculin in the treatment of non-muscle invasive bladder cancer after TURBT.
Chen L; Hu W; Li G; Guo Y; Wan Z; Yu J
J BUON; 2019; 24(4):1652-1658. PubMed ID: 31646821
[No Abstract] [Full Text] [Related]
15. Haemolytic uraemic syndrome associated with gemcitabine.
Moya-Horno I; Querol Niñerola R; Bonfill Abella T; Dalmau Pórtulas E; Gallardo-Díaz E; Saigí Grau E; Pericay Pijaume C
Clin Transl Oncol; 2010 May; 12(5):381-3. PubMed ID: 20466623
[TBL] [Abstract][Full Text] [Related]
16. What's happening in PHARMAC--where do all the submissions go? On the trail of gemcitabine.
Simpson A
N Z Med J; 2005 Nov; 118(1225):U1733. PubMed ID: 16286946
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy with gemcitabine in patients with gall-bladder carcinoma.
Rudi J
Ann Oncol; 2002 May; 13(5):807. PubMed ID: 12075753
[No Abstract] [Full Text] [Related]
18. Severe neurotoxicity caused by gemcitabine treatment.
Larsen FO; Hansen SW
Acta Oncol; 2004; 43(6):590-1. PubMed ID: 15370618
[No Abstract] [Full Text] [Related]
19. Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: response to treatment and correlation with the comprehensive geriatric assessment.
Castagneto B; Zai S; Marenco D; Bertetto O; Repetto L; Scaltriti L; Mencoboni M; Ferraris V; Botta M
Oncology; 2004; 67(1):27-32. PubMed ID: 15459492
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine in locally advanced and/or metastatic bladder cancer.
von der Maase H
Crit Rev Oncol Hematol; 2000 Jun; 34(3):175-83. PubMed ID: 10838263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
